Though many older people develop some plaques and tangles, the brains of AD patients have them to a much greater extent and in different brain locations.

A further study, administering to a single AD patient via perispinal infusion, showed rapid and significant improvement in AD symptoms.

You may be among those who are concerned that AD patients were found to have unusual aluminum levels in their brains.

The failure of semagacestat to improve the cognitive function of AD patients may be due to its non-selective blockade of γ-secretase.

Post-mortem examination of AD patients have shown decreased levels of acetylcholinesterase.

People with dementia can literally forget to eat and drink, especially because many AD patients experience decreased appetite and interest in food.

Asnis et al. (1993) found that AD patients report persistent ideation or suicide attempts less frequently than those diagnosed with major depression.

AD patients failed to use any compensatory strategies and therefore exhibited the difference in use of episodic memory and executive functioning.

MT demonstrates that AD patients can continue participating in structured music activities even when their functioning level continues to deteriorate.

Unfortunately, with the onset of AD patients will inevitable exhibit a decrease in cognitive abilities.